Anne Altmeyer - 26 Sep 2022 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Anne Altymeyer
Issuer symbol
CRBP
Transactions as of
26 Sep 2022
Net transactions value
$0
Form type
4
Filing time
28 Sep 2022, 09:38:09 UTC
Next filing
22 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option(right to buy) Award $0 +159,200 $0.000000 159,200 26 Sep 2022 Common Stock 159,200 $0.1600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.